Operating
Other Working Capital
Biogen Other Working Capital decreased by 14.8% to $89.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.4%, from $53.50M to $89.00M.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Large fluctuations may indicate timing differences in tax payments, accruals, or other non-core operational shifts.
Detailed definition
Captures the net impact of changes in operating assets and liabilities not categorized as accounts receivable, inventory...
Peer comparison
Varies significantly by industry; peers with similar business models should show comparable trends in accrual management.
Metric ID:
change_in_other_working_capitalHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.40M | -$9.70M | -$88.80M | $213.60M | -$149.90M | $34.90M | $96.80M | $15.90M | $56.10M | $46.90M | $53.50M | $22.00M | $104.40M | $89.00M |
| QoQ Change | — | -159.1% | -815.5% | +340.5% | -170.2% | +123.3% | +177.4% | -83.6% | +252.8% | -16.4% | +14.1% | -58.9% | +374.5% | -14.8% |
| YoY Change | — | — | — | — | <-999% | +139.3% | -54.7% | +110.6% | -42.0% | — | -4.6% | -53.1% | — | +66.4% |
Range-$149.90M – $213.60M
CAGR+68.3%
Avg YoY Growth-160.4%
Median YoY Growth-23.3%
Other Working Capital at Other Companies
Frequently Asked Questions
- What is Biogen's other working capital?
- Biogen (BIIB) reported other working capital of $89.00M in Q1 2026.
- How has Biogen's other working capital changed year-over-year?
- Biogen's other working capital increased by 66.4% year-over-year, from $53.50M to $89.00M.
- What does other working capital mean?
- Net cash impact from changes in miscellaneous operating assets and liabilities.